Mark Nelson

28.5k citations

418 papers · 17.5k · 2 hit papers · h-index 60

Impact in

Virology top 0.1%
- HIV Research and Treatment
Hepatology top 0.1%
- Hepatitis C virus research

Papers in

Infectious Diseases 223
- HIV/AIDS drug development and treatment 162
- HIV/AIDS Research and Interventions 100
Virology 143
- HIV Research and Treatment 142

Co-authors: Brian Gazzard (129 shared papers)Mark Bower (93 shared papers)Justin Stebbing (55 shared papers)Michael H. Goldbaum (8 shared papers)Nathan Clumeck (7 shared papers)Sundhiya Mandalia (49 shared papers)Mark Sulkowski (4 shared papers)Eduardo Lissen (3 shared papers)
Journals: AIDS (54 papers)International Journal of STD & AIDS (34 papers)HIV Medicine (22 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (18 papers)Journal of the International AIDS Society (14 papers)
Partner nations: United Kingdom United States Germany

In The Last Decade

Mark Nelson

406 papers receiving 17.0k citations

Mark Nelson's Hit Papers

align trajectories log scale

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡ 2006 · 3.5k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2006 Hepatology
1989 IEEE Transactions on Medical Imaging

Peers

Countries citing papers authored by Mark Nelson

Since Specialization

Citations

This map shows the geographic impact of Mark Nelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Nelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Nelson more than expected).

Fields of papers citing papers by Mark Nelson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Nelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Nelson. The network helps show where Mark Nelson may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Nelson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Nelson Line = papers co-authored together Mark Nelson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 418 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡ Hepatology ·Richard K. Sterling, Eduardo Lissen, Nathan Clumeck, Ricard Solà, Mendes Cassia Correa, Julio Montaner, Mark Sulkowski, Francesca J. Torriani, Doug Dieterich, David L. Thomas, Diethelm Messinger, Mark Nelson Hit paper breakdown →	2006	3450
2	Detection of blood vessels in retinal images using two-dimensional matched filters IEEE Transactions on Medical Imaging ·Subhasis Chaudhuri, S. Chatterjee, Norman P. Katz, Mark Nelson, Michael H. Goldbaum Hit paper breakdown →	1989	1208
3	Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia New England Journal of Medicine ·Adriano Lazzarin, Bonaventura Clotet, David A. Cooper, Jacques Reynes, Keikawus Arastéh, Mark Nelson, Christine Katlama, Hans-Jürgen Stellbrink, Jean-François Delfraissy, Joep M. A. Lange, Les Huson, Ralph DeMasi, Cynthia Wat, John Delehanty, Claude Drobnes, Miklos Salgo	2003	493
4	Mapping U.S. forest biomass using nationwide forest inventory data and moderate resolution information Remote Sensing of Environment ·Jock A. Blackard, Mark Finco, Eileen H. Helmer, Geoffrey R. Holden, Michael Hoppus, Dennis M. Jacobs, Andrew J. Lister, Gretchen G. Moisen, Mark Nelson, Rachel Riemann	2007	344
5	Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours AIDS ·Mark Danta, David J. Brown, Sanjay Bhagani, Oliver G. Pybus, Caroline Sabin, Mark Nelson, Martin Fisher, Margaret Johnson, Geoffrey Dusheiko	2007	313
6	Highly Active Antiretroviral Therapy and the Incidence of Non–AIDS-Defining Cancers in People With HIV Infection Journal of Clinical Oncology ·Thomas Powles, David Robinson, Justin Stebbing, Jonathan Shamash, Mark Nelson, Brian Gazzard, Sundhiya Mandelia, Henrik Møller, Mark Bower	2008	269
7	The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years AIDS ·Mark Nelson, Christine Katlama, Joan Montaner, David A. Cooper, Brian Gazzard, Bonaventura Clotet, Adriano Lazzarin, Knud Schewe, Joep M. A. Lange, Christina Wyatt, Sue Curtis, Shan-Shan Chen, Stephen A. Smith, Norbert Bischofberger, James F. Rooney	2007	268
8	Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study BMJ ·Margaret May, Mark Gompels, Valérie Delpech, Kholoud Porter, Frank Post, Margaret Johnson, David Dunn, Adrian Palfreeman, Richard Gilson, Brian Gazzard, Teresa Hill, John Walsh, Martin Fisher, Chloe Orkin, Jonathan Ainsworth, (unknown), Andrew Phillips, Clifford Leen, Mark Nelson, Jane Anderson, Caroline Sabin	2011	255
9	Measurement and classification of retinal vascular tortuosity International Journal of Medical Informatics ·William E. Hart, Michael H. Goldbaum, Brad Côté, Paul Kube, Mark Nelson	1999	252
10	Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial The Lancet HIV ·Jürgen K. Rockstroh, Mark Nelson, Christine Katlama, Jay Lalezari, Josep Mallolas, Mark Bloch, Gail Matthews, Michael S. Saag, Philippe J. Zamor, Chloe Orkin, Jacqueline Gress, Stephanie O. Klopfer, Melissa Shaughnessy, Janice Wahl, Bach-Yen Nguyen, Eliav Barr, Heather Platt, Michael Robertson, Mark Sulkowski	2015	218
11	Once-daily darunavir/ritonavir vs. lopinavir/ritonavir in treatment-naive, HIV-1-infected patients: 96-week analysis AIDS ·Anthony Mills, Mark Nelson, Dushyantha Jayaweera, Kiat Ruxrungtham, Isabel Cassetti, Pierre-Marie Girard, Cassy Workman, Inge Dierynck, Vanitha Sekar, Carline Vanden Abeele, Ludo Lavreys	2009	199
12	Immune Reconstitution Inflammatory Syndrome Associated With Kaposi's Sarcoma Journal of Clinical Oncology ·Mark Bower, Mark Nelson, Anne Marie Young, Christina Thirlwell, Tom Newsom‐Davis, Sundhiya Mandalia, T. Dhillon, Paul Holmes, Brian Gazzard, Justin Stebbing	2005	183
13	British HIV Association guidelines for HIV‐associated malignancies 2008 HIV Medicine ·Mark Bower, Simon Collins, Christopher P. Cottrill, Kate Cwynarski, Silvia Montoto, Mark Nelson, Nneka Nwokolo, Tom Powles, Justin Stebbing, Nicholas M. Wales, A. Webb	2008	168
14	A Meta-analysis of Transient Elastography for the Detection of Hepatic Fibrosis Journal of Clinical Gastroenterology ·Justin Stebbing, Lavanta Farouk, George Panos, Mike Anderson, Long R. Jiao, Sundhiya Mandalia, Mark Bower, Brian Gazzard, Mark Nelson	2010	167
15	Changes in acquired immunodeficiency syndrome–related lymphoma since the introduction of highly active antiretroviral therapy Blood ·Gail Matthews, Mark Bower, Sundhiya Mandalia, Tom Powles, Mark Nelson, Brian Gazzard	2000	152
16	Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots Journal of Medical Virology ·Ali Judd, John Parry, Matthew Hickman, Tamara McDonald, Laura Jordan, Kim Lewis, Marcela Contreras, Geoff Dusheiko, Graham R. Foster, Noël Gill, Katie J. Kemp, Janice Main, Iain M. Murray‐Lyon, Mark Nelson	2003	150
17	The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml AIDS ·José Ramón Arribas, Andrzéj Horban, Jan Gerstoft, G Fätkenheuer, Mark Nelson, Nathan Clumeck, Federico Pulido, Andrew Hill, Yvon van Delft, Thomas Stark, Christiane Moecklinghoff	2009	140
18	HIV-Associated Anal Cancer JAIDS Journal of Acquired Immune Deficiency Syndromes ·Mark Bower, Tom Powles, Tom Newsom‐Davis, Christina Thirlwell, Justin Stebbing, S Mandalia, Mark Nelson, Brian Gazzard	2004	140
19	Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study The Lancet ·Jean‐Michel Molina, Chloe Orkin, David Iser, Francisco-Xavier Zamora, Mark Nelson, Christoph Stephan, Benedetta Massetto, Anuj Gaggar, Liyun Ni, Evguenia S. Svarovskaia, Diana M. Brainard, G. Mani Subramanian, John G. McHutchison, Massimo Puoti, Jürgen K. Rockstroh	2015	133
20	Loss of Discrete Memory B Cell Subsets Is Associated with Impaired Immunization Responses in HIV-1 Infection and May Be a Risk Factor for Invasive Pneumococcal Disease The Journal of Immunology ·Melanie Hart, Alan Steel, Sally A. Clark, Graeme Moyle, Mark Nelson, Don Henderson, Robert Wilson, Frances Gotch, Brian Gazzard, Peter Kelleher	2007	132

About Mark Nelson

Mark Nelson is a scholar working on Infectious Diseases, Virology, Epidemiology, Hepatology and Oncology, having authored 418 papers that have together received 17.5k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (162 papers), HIV Research and Treatment (142 papers), HIV/AIDS Research and Interventions (100 papers), Hepatitis C virus research (80 papers), Viral-associated cancers and disorders (66 papers), HIV-related health complications and treatments (58 papers), Hepatitis B Virus Studies (44 papers) and Pneumocystis jirovecii pneumonia detection and treatment (40 papers). The work is most often cited by research in Virology (3.6k citations), Hepatology (5.1k citations), Infectious Diseases (6.2k citations), Epidemiology (7.8k citations) and Emergency Medicine (1.7k citations). Mark Nelson has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Brian Gazzard, Mark Bower, Justin Stebbing, Michael H. Goldbaum, Nathan Clumeck, Sundhiya Mandalia, Mark Sulkowski, Eduardo Lissen, Francesca J. Torriani and Julio Montaner. Their work appears in journals such as AIDS, International Journal of STD & AIDS, HIV Medicine, JAIDS Journal of Acquired Immune Deficiency Syndromes and Journal of the International AIDS Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Mark Nelson

Impact in

Papers in i

In The Last Decade

Mark Nelson

Mark Nelson's Hit Papers

Peers

Countries citing papers authored by Mark Nelson

Fields of papers citing papers by Mark Nelson

All Works

About Mark Nelson

Explore authors with similar magnitude of impact

Papers in